The initiative brings together leading centers across the country to advance comprehensive, multidisciplinary care for patients with amyloidosis — a complex group of diseases that can affect the heart and multiple organ systems.

As part of the program, the Utah Amyloidosis Program will receive financial support to help strengthen and expand its amyloidosis care efforts. The initiative will also focus on developing innovative care models designed to improve coordination, diagnosis, treatment, and long-term management for patients living with amyloidosis.

Participation in this national effort recognizes the Utah Amyloidosis Program’s commitment to collaborative, patient-centered care and its growing leadership in the field of amyloidosis treatment and research.

Through this initiative, participating centers will work together to share best practices, improve patient outcomes, and help shape the future of amyloidosis care nationwide.

The University of Utah Health Utah Amyloidosis Program includes a multidisciplinary team of specialists from hematology, cardiology, nephrology, neurology, pulmonology, gastroenterology, and related fields. Based on publicly available University of Utah sources, key physicians and leaders associated with the program include:

• Josephine Abraham, MD, MPH, FASN
• Kelsey Barrell, MD
• Spencer J. Carter, MD
• Gliceida Maria Galarza Fortuna, MD
• Aman Godara, MD
• Lindsay Maxwell, NP
• Douglas Sborov, MD
• Josef Stehlik, MD, MPH
• Jill Stratford Waldron, MSN, GPN, MS

The program also includes nurses, care coordinators, pharmacists, dietitians, therapists, transplant specialists, and research staff who support comprehensive amyloidosis care.